High-resolution chromosome banding and fragile site studies in von Hippel-Lindau syndrome

Cancer Genet Cytogenet. 1988 Mar;31(1):41-6. doi: 10.1016/0165-4608(88)90009-x.

Abstract

von Hippel-Lindau syndrome is an autosomal dominant disorder that predisposes to the development of benign and malignant tumors. The gene for von Hippel-Lindau syndrome has not yet been localized and the cytogenetics of this cancer-prone genetic disease have not been fully explored. Therefore, we did high-resolution chromosome banding of lymphocytes from patients from 14 kindreds with von Hippel-Lindau syndrome. There were 18 patients (eight male, and ten female). None of the male patients showed a detectable chromosome abnormality. However, three of the ten female patients had 45,X/46,XX/47,XXX chromosome mosaicism with predominance of the normal cell line. Fragile sites at 10q25 and 16q22 were found but both segregated independently of von Hippel-Lindau syndrome. The location of this disease gene, thus, is still unknown. The tendency to chromosome mosaicism manifest in this study suggests that there is a possible error in controlling somatic chromosome division and that error in mitosis may be causally related to the predisposition to tumor formation in von Hippel-Lindau syndrome.

MeSH terms

  • Adult
  • Angiomatosis / genetics*
  • Chromosome Banding
  • Chromosome Fragile Sites
  • Chromosome Fragility*
  • Female
  • Genetic Markers
  • Humans
  • Male
  • Middle Aged
  • Mosaicism
  • Pedigree
  • von Hippel-Lindau Disease / genetics*

Substances

  • Genetic Markers